Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Biotechnology Progress|May 28, 2022
Application of Ambr15 system for simulation of entire SARS-CoV-2 vaccine production process involving macrocarriersAvital Jayson, Michael Goldvaser, Eyal Dor, et al.
Biotechnology and Bioengineering|March 23, 2022
Optimization of VSV-ΔG-spike production process with the Ambr15 system for a SARS-COV-2 vaccineOsnat Rosen, Avital Jayson, Michael Goldvaser, et al.
Molecules (Basel, Switzerland)|June 2, 2021
Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug LibrariesAlon Ben David, Eran Diamant, Eyal Dor, et al.
Disease Models & Mechanisms|August 18, 2018
Studying the differential efficacy of postsymptom antitoxin treatment in type A versus type B botulism using a rabbit spirometry modelAmram Torgeman, Arieh Schwartz, Eran Diamant, et al.
ALTEX|November 19, 2021
A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxinsEran Diamant, Amram Torgeman, Eyal Epstein, et al.
Frontiers in Pharmacology|April 26, 2021
A Rabbit Model for Prolonged Continuous Intravenous Infusion Via a Peripherally Inserted Central CatheterEyal Dor, Tseela David, Hani Dekel Jaoui, et al.
Biotech (Basel (Switzerland))|July 13, 2022
In-Line Monitoring of Downstream Purification Processes for VSV Based SARS-CoV-2 Vaccine Using a Novel TechniqueArik Makovitzki, Avital Jayson, Ziv Oren, et al.
Vaccines|September 23, 2022
Immunologic and Protective Properties of Subunit- vs. Whole Toxoid-Derived Anti-Botulinum Equine AntitoxinAlon Ben David, Ada Barnea, Amram Torgeman, et al.
Antibodies (Basel, Switzerland)|March 24, 2022
Highly Specific Monoclonal Antibody Targeting the Botulinum Neurotoxin Type E Exposed SNAP-25 NeoepitopeAdva Mechaly, Eran Diamant, Ron Alcalay, et al.
Pageof 4